![](../images/chemdb_main_product.jpg) |
![](../images/title_product_content.gif) |
|
|
|
Riluzole |
![](../images/col_chem_composition.gif) |
6-(trifluoromethoxy)-2-benzothiazolamine |
![](../images/col_cas.gif) |
1744-22-5 |
![](../images/col_uses.gif) |
Riluzole is a drug used to treat amyotrophic lateral sclerosis. It delays the onset of ventilator-dependence or tracheostomy in selected patients and may increase survival by approximately two months. It is marketed by Aventis Pharmaceuticals Inc with the brand name Rilutek.
|
![](../images/col_property.gif) |
Assay:> 98.5% Apprearnace : Write or light yellow crystal |
Industrial field |
pharmaceutical |
|
|
![](../images/product_title_com.gif) |
|
|
|
![](../images/box_com_top2.gif) |
There are no existing companies to distribute selected chemical product |
|
![](../images/box_com_bottom.gif) |
|
|
|